Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nils Krone

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneityFelix G Riepe, Nils Krone, Michel Morlot, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Autosomal-dominant pseudohypoaldosteronism type 1 in a Turkish family is associated with a novel nonsense mutation in the human mineralocorticoid receptor geneFelix G Riepe, Nils Krone, Michel Morlot, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 15, 2005
The residue E351 is essential for the activity of human 21-hydroxylase: evidence from a naturally occurring novel point mutation compared with artificial mutants generated by single amino acid substitutionsNils Krone, Felix G Riepe, Joachim Grötzinger, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 2008
Functional and structural consequences of a novel point mutation in the CYP21A2 gene causing congenital adrenal hyperplasia: potential relevance of helix C for P450 oxidoreductase-21-hydroxylase interactionFelix G Riepe, Olaf Hiort, Joachim Grötzinger, et al.
Hormone Research|July 27, 2004
Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozoleFelix G Riepe, Inka Baus, Stephanie Wiest, et al.
Hormone Research|October 22, 2009
Congenital adrenal hyperplasia due to 11-hydroxylase deficiency--insights from two novel CYP11B1 mutations (p.M92X, p.R453Q)Nils Krone, Joachim Grötzinger, Paul-Martin Holterhus, et al.
European Journal of Endocrinology|May 31, 2011
Premature adrenarche: novel lessons from early onset androgen excessJan Idkowiak, Gareth G Lavery, Vivek Dhir, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 27, 2010
Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS)Nils Krone, Beverly A Hughes, Gareth G Lavery, et al.
Clinical Chemistry|May 25, 2002
Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasiaNils Krone, Andreas Braun, Stefanie Weinert, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2013
Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiencyNicole Reisch, Marietta Rottenkolber, Anais Greifenstein, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
Identification of a novel mutation in the human mineralocorticoid receptor gene in a german family with autosomal-dominant pseudohypoaldosteronism type 1: further evidence for marked interindividual clinical heterogeneityFelix G Riepe, Nils Krone, Michel Morlot, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Autosomal-dominant pseudohypoaldosteronism type 1 in a Turkish family is associated with a novel nonsense mutation in the human mineralocorticoid receptor geneFelix G Riepe, Nils Krone, Michel Morlot, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 15, 2005
The residue E351 is essential for the activity of human 21-hydroxylase: evidence from a naturally occurring novel point mutation compared with artificial mutants generated by single amino acid substitutionsNils Krone, Felix G Riepe, Joachim Grötzinger, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 2008
Functional and structural consequences of a novel point mutation in the CYP21A2 gene causing congenital adrenal hyperplasia: potential relevance of helix C for P450 oxidoreductase-21-hydroxylase interactionFelix G Riepe, Olaf Hiort, Joachim Grötzinger, et al.
Hormone Research|July 27, 2004
Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozoleFelix G Riepe, Inka Baus, Stephanie Wiest, et al.
Hormone Research|October 22, 2009
Congenital adrenal hyperplasia due to 11-hydroxylase deficiency--insights from two novel CYP11B1 mutations (p.M92X, p.R453Q)Nils Krone, Joachim Grötzinger, Paul-Martin Holterhus, et al.
European Journal of Endocrinology|May 31, 2011
Premature adrenarche: novel lessons from early onset androgen excessJan Idkowiak, Gareth G Lavery, Vivek Dhir, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 27, 2010
Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS)Nils Krone, Beverly A Hughes, Gareth G Lavery, et al.
Clinical Chemistry|May 25, 2002
Multiplex minisequencing of the 21-hydroxylase gene as a rapid strategy to confirm congenital adrenal hyperplasiaNils Krone, Andreas Braun, Stefanie Weinert, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2013
Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiencyNicole Reisch, Marietta Rottenkolber, Anais Greifenstein, et al.
Pageof 10